141 related articles for article (PubMed ID: 9164601)
21. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
Yadava A; Sattabongkot J; Washington MA; Ware LA; Majam V; Zheng H; Kumar S; Ockenhouse CF
Infect Immun; 2007 Mar; 75(3):1177-85. PubMed ID: 17158893
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
[TBL] [Abstract][Full Text] [Related]
23. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin.
Leal MT; Camacho AG; Teixeira LH; Bargieri DY; Soares IS; Tararam CA; Rodrigues MM
Clin Vaccine Immunol; 2013 Sep; 20(9):1418-25. PubMed ID: 23863502
[TBL] [Abstract][Full Text] [Related]
25. Serological responses to a soluble recombinant circumsporozoite protein-VK210 of Plasmodium vivax (rPvCSP-VK210) among Iranian malaria patients.
Nateghpour M; Etemadi S; Motevalli Haghi A; Eslami H; Mohebali M; Farivar L
Eur J Med Res; 2021 Nov; 26(1):134. PubMed ID: 34823591
[TBL] [Abstract][Full Text] [Related]
26. Trials for the co-expression of the merozoite surface protein-1 and circumsporozoite protein genes of Plasmodium vivax.
Lee C; Chung KW; Kim TS; Choi KM; Choi YK; Chung NJ; Rhie HG; Lee HS; Lee SJ; Lee HW
Exp Parasitol; 2011 Nov; 129(3):227-33. PubMed ID: 21907198
[TBL] [Abstract][Full Text] [Related]
27. Inducing a cell-mediated immune response against peptides of the Plasmodium vivax circumsporozoite protein.
Thomas BE; Sridevi K; Chopra N; Haq W; Rao DN
Ann Trop Med Parasitol; 2001 Sep; 95(6):573-86. PubMed ID: 11672463
[TBL] [Abstract][Full Text] [Related]
28. Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates.
González JM; Hurtado S; Arévalo-Herrera M; Herrera S
Mem Inst Oswaldo Cruz; 2001 Jul; 96(5):709-12. PubMed ID: 11500776
[TBL] [Abstract][Full Text] [Related]
29. T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee.
Nardin E; Clavijo P; Mons B; van Belkum A; Ponnudurai T; Nussenzweig RS
J Immunol; 1991 Mar; 146(5):1674-8. PubMed ID: 1704402
[TBL] [Abstract][Full Text] [Related]
30. HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria.
Oliveira-Ferreira J; Pratt-Riccio LR; Arruda M; Santos F; Daniel Ribeiro CT; Goldberg AC; Banic DM
Acta Trop; 2004 Sep; 92(1):63-9. PubMed ID: 15301976
[TBL] [Abstract][Full Text] [Related]
31. Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein.
Almeida AP; Dias MO; Vieira Cde A; Chávez-Olórtegui C; Gazzineli RT; Rodrigues MM; Fujiwara RT; Bruna-Romero O
Vaccine; 2014 Apr; 32(19):2181-7. PubMed ID: 24582631
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibody to heterologous circumsporozoite protein of Plasmodium vivax in Thailand.
Wirtz RA; Rosenberg R; Sattabongkot J; Webster HK
Lancet; 1990 Sep; 336(8715):593-5. PubMed ID: 1975379
[TBL] [Abstract][Full Text] [Related]
33. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.
Charoenvit Y; Collins WE; Jones TR; Millet P; Yuan L; Campbell GH; Beaudoin RL; Broderson JR; Hoffman SL
Science; 1991 Feb; 251(4994):668-71. PubMed ID: 1704150
[TBL] [Abstract][Full Text] [Related]
34. Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct.
Céspedes N; Jiménez E; Lopez-Perez M; Rubiano K; Felger I; Alonso P; Arévalo-Herrera M; Corradin G; Herrera S
Vaccine; 2014 May; 32(26):3179-86. PubMed ID: 24731811
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies to the repeat epitope of the circumsporozoite protein of Plasmodium vivax in San Luis Potosi, Mexico.
Mota J; Coreño O; Cochrane AH; Ramos C
Arch Med Res; 1996; 27(2):233-6. PubMed ID: 8696070
[TBL] [Abstract][Full Text] [Related]
36. Immune response against the non-repeat region (293-310) of the circumsporozoite protein of Plasmodium vivax.
Shahi S; Kumar P; Kamboj KK; Rao DN
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):748-56. PubMed ID: 9656398
[TBL] [Abstract][Full Text] [Related]
37. Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax.
Zevering Y; Khamboonruang C; Rungruengthanakit K; Tungviboonchai L; Ruengpipattanapan J; Bathurst I; Barr P; Good MF
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6118-22. PubMed ID: 7517041
[TBL] [Abstract][Full Text] [Related]
38. Antibody response of humans to the circumsporozoite protein of Plasmodium vivax.
Franke ED; Lucas CM; San Roman E
Infect Immun; 1991 Aug; 59(8):2836-8. PubMed ID: 1855998
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of antibody to the variant repeat of the circumsporozoite protein of Plasmodium vivax in Peru.
Franke ED; Lucas CM; San Roman E; Wirtz RA
Am J Trop Med Hyg; 1992 Jun; 46(6):708-10. PubMed ID: 1621895
[TBL] [Abstract][Full Text] [Related]
40. Analysis of circumsporozoite protein-specific immune responses following recent infection with Plasmodium vivax.
Suphavilai C; Looareesuwan S; Good MF
Am J Trop Med Hyg; 2004 Jul; 71(1):29-39. PubMed ID: 15238685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
